Selected Publications/Patents

Orabi A, Bieringer M, Geerlof A, Bruss V
An Aptamer against the Matrix Binding Domain on the Hepatitis B Virus Capsid Impairs Virion Formation.
J Virol. 2015;89(18): 9281-7

Cui X, Luckenbaugh L, Bruss V, Hu J
Alteration of Mature Nucleocapsid and Enhancement of Covalently Closed Circular DNA Formation by Hepatitis B Virus Core Mutants Defective in Complete-Virion Formation.
J Virol. 2015;89(19): 10064-72

Schittl B, Bruss V
Mutational profiling of the variability of individual amino acid positions in the hepatitis B virus matrix domain.
Virology. 2014;458-459: 183-9

Siegler VD, Bruss V
Role of transmembrane domains of hepatitis B virus small surface proteins in subviral-particle biogenesis.
J Virol. 2013;87(3): 1491-6

Pairan A, Bruss V
Functional surfaces of the hepatitis B virus capsid.
J Virol. 2009;83(22): 11616-23

Gudima S, He Y, Chai N, Bruss V, Urban S, Mason W, Taylor J.
Primary human hepatocytes are susceptible to infection by hepatitis delta virus assembled with envelope proteins of woodchuck hepatitis virus.
J Virol 2008;82:7276-7283.

Gudima S, Meier A, Dunbrack R, Taylor J, and Bruss V
Two potentially important elements of the hepatitis B virus large envelope protein are dispensable for the infectivity of hepatitis delta virus.
J Virol 2007;81:4343-44347.

Gudima S, He Y, Meier A, Chang J, Chen R, Jarnik M, Nicolas E, Bruss V, and Taylor J
Assembly of hepatitis delta virus: particle characterization, including the ability to infect primary human hepatocytes.
J Virol 2007;81:3608-3617.

Schormann W, Kraft A, Ponsel D, and Bruss V
Hepatitis B virus particle formation in the absence of pregenomic RNA and reverse transcriptase.
J Virol 2006; 80:4187-4190.

Kluge B, Schläger M, Pairan A, and Bruss V
Determination of the minimal distance between the matrix and transmembrane domains of the large hepatitis B virus envelope protein.
J Virol 2005;79:7918-7921.

Ponsel D and Bruss V
Mapping of amino acid side chains on the surface of hepatitis B virus capsids required for envelopment and virion formation.
J Virol 2003;77:416-422.

Book Chapters

Gerlich WH, Bruss V, Heermann KH, Marquard O und Seifer M (1987) Presurface and precore products of human hepatitis B virus. In: Robinson W, Koike K und Will H (Herausgeber), “Hepadnaviruses”, UCLA Symposia on Molecular and Cellular Biology, New Series, Vol 70, p. 147-160. Alan R. Liss, Inc. New York.

Gerlich WH, Heermann KH, Bruss V, Höhne M, Krone B, Schaefer S und Seifer M (1988) Structure, expression and potential oncogenicity of hepatitis B virus proteins. In: Bannasch P und Keppler D (Herausgeber), “Liver Carcinoma”, p.139-163, Kluver, Dordrecht.

Melegari M, Bruss V und Gerlich WH (1991) The arginine-rich carboxy-terminal domain is necessary for RNA packaging by hepatitis B core protein. In Hollinger FB, Lemon SM und Margolis HS (Herausgeber), „Viral hepatitis and liver disease”, p. 164-168, Williams and Wilkins, Baltimore, USA.

Gerlich WH und Bruss V (1993) Functions of hepatitis B virus proteins and molecular targets for protective immunity. In: Ellis RW (Herausgeber), “Hepatitis B vaccines in clinical practice”, p. 41-82, Marcel Dekker, New York.

Bruss V (2004) Processing of hepatitis B virus surface proteins. Methods Mol Med 95:189-198.


Bruss V (2007) Hepatitis B virus morphogenesis. World J Gastroenterol 13:65-73.

Leider ist der Eintrag nur auf English verfügbar.